SCHEMBL8307965

SCHEMBL8307965

COc1cc2c(Nc3ccc(C(=O)c4ccccc4)c(Cl)c3)ncnc2cc1OC(C)=O

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EGFR P00533 11/20 0.65
MAPK14 Q16539 5/20 0.65
AURKA O14965 2/20 0.61
AURKB Q96GD4 2/20 0.61
KDR P35968 12/20 0.60
RET P07949 2/20 0.57
EPHB4 P54760 2/20 0.57
ERBB2 P04626 1/20 0.57
INSR P06213 1/20 0.57
FBP1 P09467 1/20 0.57
PDGFRB P09619 1/20 0.57
FLT4 P35916 1/20 0.57
CLK1 P49759 1/20 0.57
TEK Q02763 1/20 0.57
KIF5B P33176 1/20 0.57
LCK P06239 1/20 0.55
EPHA2 P29317 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8309364 0.95 EGFR (0.70) EGFRMAPK14AURKAAURKBKDR
Hydrochloric Acid SCHEMBL8307571 0.94 EGFR (0.69) EGFRMAPK14AURKAAURKBKDR
SCHEMBL8304875 0.89 AURKB (0.69) EGFRMAPK14AURKAAURKBKDR
SCHEMBL8309261 0.89 EGFR (0.64) EGFRMAPK14AURKAAURKBKDR
Hydrochloric Acid SCHEMBL8813291 0.87 KDR (0.67) EGFRMAPK14AURKAAURKBKDR
SCHEMBL22630824 0.86 KDR (0.69) EGFRAURKAAURKBKDRRET
SCHEMBL8306628 0.86 EGFR (0.66) EGFRAURKAAURKBKDRRET
Hydrochloric Acid SCHEMBL8309441 0.85 EGFR (0.59) EGFRMAPK14AURKAAURKBKDR
SCHEMBL5240218 0.84 EGFR (0.79) EGFRMAPK14AURKAAURKBKDR
SCHEMBL30968994 0.84 EGFR (0.82) EGFRAURKAAURKBKDREPHB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0790986-B1 ANILINE DERIVATIVES ZENECA LTD (GB) 1999-01-20 EP disclosed
US-5821246-A USEFUL AS TYROSINE KINASE INHIBITORS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES SUCH AS CANCER ZENECA LIMITED (GB) 1998-10-13 US disclosed
EP-0790986-A1 ANILINE DERIVATIVES ZENECA LIMITED (GB) 1997-08-27 EP disclosed
WO-1996015118-A1 ANILINE DERIVATIVES ZENECA LIMITED (GB) 1996-05-23 WO disclosed